| Disease ID | Disease name | Source of annotation with TNF | OMIM link | Number of associated genes | genes |
|---|---|---|---|---|---|
| 611162 | MALARIA, SUSCEPTIBILITY TO | OMIM | link to OMIM | 16 | FCGR2A, TIRAP, ICAM1, ACKR1, G6PD, GYPC, TNF, SLC4A1, NOS2, HBB, CISH, GYPB, FCGR2B, CR1, CD36, GYPA |
| 157300 | MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1 | OMIM | link to OMIM | 3 | EDNRA, ESR1, TNF |
| 600807 | ASTHMA, SUSCEPTIBILITY TO | ClinVar, OMIM | link to OMIM | 13 | HLA-G, SCGB1A1, PLA2G7, PHF11, MUC7, TNF, HNMT, IL13, SPINK5, SCGB3A2, CCL11, ALOX5, ADRB2 |
Download the gene annotation in CSV format
| KEGG pathway | KEGG ID | KEGG IC |
|---|---|---|
| Pertussis | hsa05133 | 6.46 |
| Legionellosis | hsa05134 | 6.88 |
| Natural killer cell mediated cytotoxicity | hsa04650 | 5.53 |
| Asthma | hsa05310 | 7.34 |
| Allograft rejection | hsa05330 | 6.91 |
| Graft-versus-host disease | hsa05332 | 6.84 |
| Osteoclast differentiation | hsa04380 | 5.64 |
| Hypertrophic cardiomyopathy (HCM) | hsa05410 | 6.21 |
| Type I diabetes mellitus | hsa04940 | 6.79 |
| NF-kappa B signaling pathway | hsa04064 | 6.21 |
| Dilated cardiomyopathy | hsa05414 | 6.08 |
| Cytokine-cytokine receptor interaction | hsa04060 | 4.67 |
| Adipocytokine signaling pathway | hsa04920 | 6.6 |
| African trypanosomiasis | hsa05143 | 7.68 |
| Antigen processing and presentation | hsa04612 | 6.04 |
| Chagas disease (American trypanosomiasis) | hsa05142 | 5.99 |
| Systemic lupus erythematosus | hsa05322 | 5.95 |
| Leishmaniasis | hsa05140 | 6.32 |
| Amoebiasis | hsa05146 | 5.82 |
| Non-alcoholic fatty liver disease (NAFLD) | hsa04932 | 5.51 |
| Malaria | hsa05144 | 7.15 |
| Toxoplasmosis | hsa05145 | 5.71 |
| Influenza A | hsa05164 | 5.21 |
| Herpes simplex infection | hsa05168 | 5.08 |
| HTLV-I infection | hsa05166 | 4.59 |
| Hepatitis C | hsa05160 | 5.68 |
| Hepatitis B | hsa05161 | 5.52 |
| TGF-beta signaling pathway | hsa04350 | 6.41 |
| Apoptosis | hsa04210 | 6.23 |
| Proteoglycans in cancer | hsa05205 | 5.02 |
| Rheumatoid arthritis | hsa05323 | 6.05 |
| Inflammatory bowel disease (IBD) | hsa05321 | 6.43 |
| Toll-like receptor signaling pathway | hsa04620 | 6.0 |
| NOD-like receptor signaling pathway | hsa04621 | 6.88 |
| RIG-I-like receptor signaling pathway | hsa04622 | 6.62 |
| T cell receptor signaling pathway | hsa04660 | 6.01 |
| Fc epsilon RI signaling pathway | hsa04664 | 6.6 |
| Hematopoietic cell lineage | hsa04640 | 6.18 |
| MAPK signaling pathway | hsa04010 | 4.63 |
| TNF signaling pathway | hsa04668 | 5.96 |
| Type II diabetes mellitus | hsa04930 | 7.12 |
| mTOR signaling pathway | hsa04150 | 6.72 |
| Tuberculosis | hsa05152 | 5.17 |
| Amyotrophic lateral sclerosis (ALS) | hsa05014 | 7.01 |
| Alzheimer's disease | hsa05010 | 5.34 |
| REACTOME pathway | REACTOME ID | REACTOME IC |
|---|---|---|
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.4 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.28 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.7 |
| Immune System | R-HSA-168256 | 2.37 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
| Signal Transduction | R-HSA-162582 | 1.78 |
| Death Receptor Signalling | R-HSA-73887 | 8.52 |
| TNF signaling | R-HSA-75893 | 9.08 |
| Developmental Biology | R-HSA-1266738 | 3.48 |
| GO term | GO ID | GO IC |
|---|---|---|
| cytokine receptor binding | GO:0005126 | 4.14 |
| transcription regulatory region DNA binding | GO:0044212 | 3.03 |
| enzyme binding | GO:0019899 | 2.27 |
| tumor necrosis factor receptor superfamily binding | GO:0032813 | 5.89 |
| nucleic acid binding | GO:0003676 | 1.44 |
| protein binding | GO:0005515 | 0.46 |
| organic cyclic compound binding | GO:0097159 | 1.05 |
| regulatory region DNA binding | GO:0000975 | 3.03 |
| regulatory region nucleic acid binding | GO:0001067 | 3.03 |
| tumor necrosis factor receptor binding | GO:0005164 | 6.3 |
| cytokine activity | GO:0005125 | 4.34 |
| binding | GO:0005488 | 0.18 |
| protease binding | GO:0002020 | 5.08 |
| DNA binding | GO:0003677 | 1.92 |
| receptor binding | GO:0005102 | 2.43 |
| heterocyclic compound binding | GO:1901363 | 1.06 |
| identical protein binding | GO:0042802 | 2.63 |